Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.

We are currently collaborating with more than 20 biotech and pharmaceutical companies, as well as numerous academic medical centers, to help accelerate the development of new targeted therapies. Utilizing our molecular information platform, we enable better selection of drug candidates, a better understanding of mechanisms of sensitivity or resistance, more efficient clinical trial design and faster patient recruitment into clinical trials. Ultimately, we believe these partnerships will accelerate the delivery of safe, effective targeted therapies available for patients with cancer.